// App-Quantinova.ai

1079 : Assessing Psoriatic Arthritis Treatment Trends and Patient Journeys Between 2012 and 2018

Researchers

Presenter

  • M. Elaine Husni

Principal Investigators

  • Sven Richter

  • Corey Pelletier

  • Marc Tian

Medical Centers

  • Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Foundation, Cleveland, OH

  • Celgene Corporation, Summit, NJ

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Dermatology

  • Oncology (ONC)

  • Musculoskeletal

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

  • Psoriatic arthritis

  • Solid malignancies

Biomarkers

  • Tumor necrosis factor

Drug/Treatment

  • Hydroxychloroquine

  • Sulfasalazine

  • Oraprine

  • Certolizumab pegol

  • Cyclosporine eent

  • Methotrexate

  • HWA-486

  • secukinumab

  • Ustekinumab

  • Adalimumab

  • Apremilast

  • Infliximab

  • Etanercept

  • CHS-0214

  • LY2439821

  • golimumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved